121 related articles for article (PubMed ID: 15514928)
1. HLA-G gene activation in tumor cells involves cis-acting epigenetic changes.
Mouillot G; Marcou C; Rousseau P; Rouas-Freiss N; Carosella ED; Moreau P
Int J Cancer; 2005 Mar; 113(6):928-36. PubMed ID: 15514928
[TBL] [Abstract][Full Text] [Related]
2. Induction of HLA-G expression in a melanoma cell line OCM-1A following the treatment with 5-aza-2'-deoxycytidine.
Yan WH; Lin AF; Chang CC; Ferrone S
Cell Res; 2005 Jul; 15(7):523-31. PubMed ID: 16045815
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic control of the major histocompatibility complex class Ib gene HLA-G in trophoblast cell lines.
Holling TM; Bergevoet MW; Wierda RJ; van Eggermond MC; van den Elsen PJ
Ann N Y Acad Sci; 2009 Sep; 1173():538-44. PubMed ID: 19758196
[TBL] [Abstract][Full Text] [Related]
4. Hypoxia modulates HLA-G gene expression in tumor cells.
Mouillot G; Marcou C; Zidi I; Guillard C; Sangrouber D; Carosella ED; Moreau P
Hum Immunol; 2007 Apr; 68(4):277-85. PubMed ID: 17400064
[TBL] [Abstract][Full Text] [Related]
5. Modulation of HLA-G expression.
Polakova K; Bandzuchova E; Tirpakova J; Kuba D; Russ G
Neoplasma; 2007; 54(6):455-62. PubMed ID: 17949227
[TBL] [Abstract][Full Text] [Related]
6. Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression.
Willers J; Urosevic M; Laine E; Geertsen R; Kündig T; Burg G; Dummer R
J Invest Dermatol; 2001 Dec; 117(6):1498-504. PubMed ID: 11886514
[TBL] [Abstract][Full Text] [Related]
7. Extraembryonic expression of the human MHC class I gene HLA-G in transgenic mice. Evidence for a positive regulatory region located 1 kilobase 5' to the start site of transcription.
Schmidt CM; Ehlenfeldt RG; Athanasiou MC; Duvick LA; Heinrichs H; David CS; Orr HT
J Immunol; 1993 Sep; 151(5):2633-45. PubMed ID: 8360483
[TBL] [Abstract][Full Text] [Related]
8. Progesterone regulates HLA-G gene expression through a novel progesterone response element.
Yie SM; Xiao R; Librach CL
Hum Reprod; 2006 Oct; 21(10):2538-44. PubMed ID: 16684846
[TBL] [Abstract][Full Text] [Related]
9. HLA-G gene repression is reversed by demethylation.
Moreau P; Mouillot G; Rousseau P; Marcou C; Dausset J; Carosella ED
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):1191-6. PubMed ID: 12552087
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms controlling constitutive and IFN-gamma-inducible HLA-G expression in various cell types.
Lefebvre S; Moreau P; Guiard V; Ibrahim EC; Adrian-Cabestre F; Menier C; Dausset J; Carosella ED; Paul P
J Reprod Immunol; 1999 Jul; 43(2):213-24. PubMed ID: 10479057
[TBL] [Abstract][Full Text] [Related]
11. HLA-G gene transcriptional regulation in trophoblasts and blood cells: differential binding of nuclear factors to a regulatory element located 1.1 kb from exon 1.
Moreau P; Paul P; Gourand L; Prost S; Dausset J; Carosella E; Kirszenbaum M
Hum Immunol; 1997 Jan; 52(1):41-6. PubMed ID: 9021408
[TBL] [Abstract][Full Text] [Related]
12. HLA-G expression in malignant melanoma.
Rebmann V; Wagner S; Grosse-Wilde H
Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
[TBL] [Abstract][Full Text] [Related]
13. Demethylating agent 5-aza-2'-deoxycytidine activates HLA-G expression in human leukemia cell lines.
Poláková K; Bandzuchová E; Kuba D; Russ G
Leuk Res; 2009 Apr; 33(4):518-24. PubMed ID: 18823661
[TBL] [Abstract][Full Text] [Related]
14. The 14 bp deletion-insertion polymorphism in the 3' UT region of the HLA-G gene influences HLA-G mRNA stability.
Rousseau P; Le Discorde M; Mouillot G; Marcou C; Carosella ED; Moreau P
Hum Immunol; 2003 Nov; 64(11):1005-10. PubMed ID: 14602228
[TBL] [Abstract][Full Text] [Related]
15. Increase in HLA-G1 proteolytic shedding by tumor cells: a regulatory pathway controlled by NF-kappaB inducers.
Zidi I; Guillard C; Marcou C; Krawice-Radanne I; Sangrouber D; Rouas-Freiss N; Carosella ED; Moreau P
Cell Mol Life Sci; 2006 Nov; 63(22):2669-81. PubMed ID: 17072500
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic changes within the promoter region of the HLA-G gene in ovarian tumors.
Menendez L; Walker LD; Matyunina LV; Totten KA; Benigno BB; McDonald JF
Mol Cancer; 2008 May; 7():43. PubMed ID: 18498645
[TBL] [Abstract][Full Text] [Related]
17. Expression and regulation of non-classical HLA-G in renal cell carcinoma.
Dunker K; Schlaf G; Bukur J; Altermann WW; Handke D; Seliger B
Tissue Antigens; 2008 Aug; 72(2):137-48. PubMed ID: 18721274
[TBL] [Abstract][Full Text] [Related]
18. Regulation of classical HLA class I genes in human choriocarcinoma cells by nuclear proteins binding to MHC class I regulatory elements.
Wakimoto A; Ohashi K; Koyama M; Kato M; Tsutsui T; Saji F; Tanizawa O
Am J Reprod Immunol; 1995 Nov; 34(5):323-31. PubMed ID: 8595132
[TBL] [Abstract][Full Text] [Related]
19. Specific binding of nuclear factors to the HLA-G gene promoter correlates with a lack of HLA-G transcripts in first trimester human fetal liver.
Moreau P; Lefebvre S; Gourand L; Dausset J; Carosella ED; Paul P
Hum Immunol; 1998 Dec; 59(12):751-7. PubMed ID: 9831130
[TBL] [Abstract][Full Text] [Related]
20. HLA-E is the only class I gene that escapes CpG methylation and is transcriptionally active in the trophoblast-derived human cell line JAR.
Boucraut J; Guillaudeux T; Alizadeh M; Boretto J; Chimini G; Malecaze F; Semana G; Fauchet R; Pontarotti P; Le Bouteiller P
Immunogenetics; 1993; 38(2):117-30. PubMed ID: 7683306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
